Bradykinin B2 Receptor Antagonists [MoA] - N0000182964

Pharmacologic Code	N0000182964
Pharmacologic Name	Bradykinin B2 Receptor Antagonists
Pharmacologic Uses	bradykinin B2 receptor antagonist
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 9 products whose active ingredient are classified under the same pharmacologic class Bradykinin B2 Receptor Antagonists [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	69097-664	Icatibant	Non-Proprietary Name: Icatibant	Injection	Subcutaneous	Cipla Usa Inc.	ACTIVE
	62332-654	Icatibant	Non-Proprietary Name: Icatibant	Injection	Subcutaneous	Alembic Pharmaceuticals Inc.	ACTIVE
	0093-3066	Icatibant	Non-Proprietary Name: Icatibant	Injection, Solution	Subcutaneous	Teva Pharmaceuticals Usa, Inc.	ACTIVE
	70709-013	Sajazir	Non-Proprietary Name: Icatibant	Injection	Subcutaneous	Cycle Pharmaceuticals Ltd-uk	ACTIVE
	24201-207	Icatibant	Non-Proprietary Name: Icatibant	Injection, Solution	Subcutaneous	Hikma Pharmaceuticals Usa Inc.	ACTIVE
	46708-654	Icatibant	Non-Proprietary Name: Icatibant	Injection	Subcutaneous	Alembic Pharmaceuticals Limited	ACTIVE
	63323-574	Icatibant	Non-Proprietary Name: Icatibant	Injection, Solution	Subcutaneous	Fresenius Kabi Usa, Llc	ACTIVE
	55150-351	Icatibant	Non-Proprietary Name: Icatibant	Injection, Solution	Subcutaneous	Eugia Us Llc	ACTIVE
	54092-702	Firazyr	Non-Proprietary Name: Icatibant Acetate	Injection, Solution	Subcutaneous	Takeda Pharmaceuticals America, Inc.	ACTIVE